2Guido T. Multiple myeloma and other plasma cell disorders. Hofman R. Hematology- basic principles and practice. 4th ed. Elsevier, 2005. 1501 - 1505.
3Sakhuja V,Jha V, Varma S, et al. Renal involvement in multiple myeloma: a 10 - year study. Ren fail, 2000,22 (4) : 465 - 477.
4Zaidi A, Vesole D. Multiple myeloma, an old disease with new hope for the future. CA Cancer J Clin,2001,51(5) :273 -289.
5Podczaski E, Cain J. Multiple Myeloma. Clin Obstet Gynecol, 2002,45(3) :928 - 938.
6陈楠 史浩.268例单克隆免疫球蛋白血症肾脏损害分析[J].中国医学论坛报,2007,9.
7Kyle RA. Monoclonal gammopathy of undetermined significance and solitary plasma Cytoma. Implications for progression to overt multiple myeloma. Hematol Oncol Clin North Am, 1997, 11 (1) :71 - 87.
8Sanders PW, Herrera GA, Galla JH. Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo. Kidney Int, 1987,32(6) :851 - 861.
9Gu X, Barrios R, Cartwright J, et al. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy. Hum Pathol, 2003,34 (3) : 270 - 277.
10Markowitz GS. Dysproteine - mia and the kidney. Adv Anat Pathol, 2004,11 ( 1 ) : 49 - 63.
5Rawstron AC,Orfao A,Beksac M,et al. Report of the Eu- ropean Myeloma Network on multiparametric flow cytom-etry in multiple myeloma and related disorders [J]. H aematologica, 2008,93 (3) .. 431-438.
